Regulation of muscarinic M2 receptors

Life Sciences

Volumn 60, Issue 13-14, 1997, Pages 1015-1021

  Barnes, Peter J ^a   Haddad, El Bdaoui ^a   Rousell, Jonathan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cytokines; M2 receptors; MAP kinase; protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 8 BROMO CYCLIC AMP; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CARBACHOL; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYTOKINE; FORSKOLIN; INTERLEUKIN 1BETA; MESSENGER RNA; METHYLSCOPOLAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PHORBOL DIBUTYRATE; PLATELET DERIVED GROWTH FACTOR; PROCATEROL; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; QUINUCLIDINYL BENZILATE; RADIOLIGAND; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; MUSCARINIC RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ASTHMA; CONFERENCE PAPER; EMBRYO; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LUNG FIBROBLAST; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; ANIMAL; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; ENZYME ACTIVATION; HUMANS; MUSCARINIC AGONISTS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN KINASE C; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, MUSCARINIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030609972     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00042-8     Document Type: Conference Paper

References (29)

1. J.C.W. MAK AND P.J. BARNES, Am. Rev. Respir. Dis. 141 1559-1568 (1990).
2. J.C.W. MAK, J.N. BARANIUK AND P.J. BARNES, Am J Respir Cell Mol Biol 7 344-348 (1992).
3. P.J. BARNES, Life Sci 52 521-528 (1993).
4. N. WATSON, H. MAGNUSSEN AND K.F. RABE, Eur J Pharmacol 275 307-310 (1995).
5. P.J. BARNES, Physiol Rev 72 699-729 (1992).
6. H.J. PATEL, P.J. BARNES, T. TAKAHASHI, S. TADJKARIMI, M.H. YACOUB AND M.G. BELVISI, Am J Resp Crit Care Med 752 872-878 (1995).
7. P.A.H. MINETTE, J. LAMMERS, C.M.S. DIXON, M.T. MCCUSKER AND P.J. BARNES, J. Appl. Physiol. 67 2461-2465 (1989).
8. L.E. AYALA AND T. AHMED, Chest 96 1285-1291 (1991).
9. E.-B. HADDAD, J.C.W. MAK AND P.J. BARNES, Am J Physiol in press (1996).
10. A.D. FRYER AND D.B. JACOBY, Life Sci 52 529-536 (1993).
11. E.-B. HADDAD, J. ROUSELL, J.C.W. MAK AND P.J. BARNES, Br J Pharmacol 116 2027-2032 (1995).
12. F. FUKAMAUCHI, P.A. SAUNDERS, C. HOUGH AND D. CHUANG, Mol Pharmacol 44 940-949 (1993).
13. J ROUSELL, E.-B. HADDAD, B.L.J. WEBB, M.A. GIEMBYCZ, J.C.W. MAK AND P.J. BARNES, Mol Pharmacol 49 629-635 (1996).
14. J. ROUSELL, E. HADDAD, J.C.W. MAKAND P.J. BARNES, J Biol Chem 270 7213-7218 (1995).
15. Y. NISHIZUKA, FASEB J 9 4484-496 (1995).
16. U. SIEBENLIST, G. FRANZUSO AND R. BROWN, Ann. Rev. Cell. Biol. 10 405-455 (1994).
17. M. PFAHL, Endocrine Revs 14 651-658 (1993).
18. M.H. COBB AND E.J. GOLDSMITH, J Biol Chem 270 14843-14846 (1995).
19. D.R. ALESSI, A. CUENDA, P. COHEN, D.T. DUDLEY AND A.R. SALTIEL, J Biol Chem 270 27489-27494 (1995).
20. E.-B. HADDAD, J. ROUSELL AND P.J. BARNES, Am J Respir Crit Care Med in press (1997).
21. J. MASSAGUE, L. ATTASANO AND J.L. WRANA, Trends Cell Biol 4 172-178 (1994).
22. E.-B. HADDAD, J. ROUSELL, J.C.W. MAK, I.M. ADCOCK AND P.J. BARNES, Mol Pharmacol 49 781-787 (1996).
23. E.-B. HADDAD, J. ROUSELL AND P.J. BARNES, Eur J Pharmacol (Mol Pharmacol) 283 255-258 (1995).
24. P.J. BARNES, Am J Resp Crit Care Med 150 S42-S49 (1994).
25. E.-B. HADDAD, J. ROUSELL AND P.J. BARNES, J Biol Chem 271 (in press) (1996).
26. R. KOLESNICK AND D.W. GOLDE, Cell 77 325-328 (1919).
27. E. CORONEOS, Y. WANG, J.R. PANUSKA, D.J. TEMPLETON AND M. KESTER, Biochem J 376 13-17 (1996).
28. J. ROUSELL, E.-B. HADDAD AND P.J. BARNES, Am J Respir Crit Care Med 153 A223 (1996).
29. I.C. WOOD, A. ROOPRA, C. HARRINGTON AND N.J. BUCKLEY, J Biol Chem 270 30933-30940 (1995).